Delivery Order SPE2DB22D3501-SPE2DB24FWA55
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,337.79 firm fixed-price delivery order is for the supply of 4565188888 GADAVIST 7.5 MMOL/7.5 ML VIAL 7.5ML, a medical product. The contract has an ultimate completion date of July 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,834.97 firm fixed-price delivery order is for Gadavist 10 mmol/10 ml vials. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This award is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This federal contract award is for the delivery of GADAVIST 10 MMOL/10 ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,165.20 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award date is April 1, 2024, with an ultimate completion date of April 2, 2024. This delivery order is part of a larger indefinite delivery...
This federal contract award, valued at $1,513.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GADAVIST 15 MMOL/15 ML VIAL 15ML, a medical commodity with a completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,164.96 firm fixed price delivery order is for the supply of the pharmaceutical product Gadavist 7.5 mmol/7.5 ml vial, with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025....
This federal contract award is a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Gadavist 10 MMOL/10 ML vials. The $2,051.44 firm fixed-price contract is funded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through June 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) valued...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Gadavist (10 mL vial). The $5,505.64 firm-fixed-price contract has an ultimate completion date of August 24, 2022. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a range of pharmaceutical and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist 1 mmol/ml bulk vials, a specialty pharmaceutical product. The contract has a ceiling value of $1,704.90 and a performance period running through March 10, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award, valued at $1,828.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Gadavist, a 10 mL vial of a 10 mmol/mL solution, with a performance period ending on May 6, 2025. The contract is a delivery order and is priced on a firm fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Gadavist 10 mmol/10 ml vial, 10 ml. The contract, with a ceiling value of $4,096.66, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency, a defense agency. The contract has an ultimate completion date of April 25, 2024 and was awarded on April 24, 2024. This award is not associated with...